According to The Insight Partners, the Antifungal Drugs Market is expected to reach US$ 21.16 billion by 2031 and is anticipated to register a CAGR of 4.2% during 2025–2031. The market is experiencing steady expansion due to the increasing incidence of fungal infections worldwide, growing awareness regarding fungal disease management, and the introduction of innovative treatment...